Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions

Psychological Medicine

Volumn 42, Issue 6, 2012, Pages 1261-1272

  Martins, S S ^a   Fenton, M C ^a   Keyes, K M ^a   Blanco, C ^a   Zhu, H ^a   Storr, C L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Anxiety disorders; Mood disorders; Non medical prescription opioid use; Temporal sequence

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; DISEASE PREDISPOSITION; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MOOD DISORDER; OPIATE ADDICTION; SELF MEDICATION; THEORETICAL MODEL; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANXIETY DISORDERS; CAUSALITY; DISEASE SUSCEPTIBILITY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MOOD DISORDERS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; SELF MEDICATION; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84860751822     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711002145     Document Type: Article

References (44)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.
2. Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA (2008). Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug and Alcohol Dependence 94, 38-47.
3. Blanco C, Alderson D, Ogburn E, Grant BF, Nunes EV, Hatzenbuehler ML, Sasin DS (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug and Alcohol Dependence 90, 252-260.
4. Boyd CJ, McCabe SE (2009). Coming to terms with nonmedical use of prescription medications. Substance Abuse Treatment, Prevention and Policy 3, 22.
5. Brady KT, Sinha R (2005). Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. American Journal of Psychiatry 162, 1483-1493. (Pubitemid 41105562)
6. Brands B, Paglia-Boak A, Sproule BA, Leslie K, Adlaf EM (2010). Nonmedical use of opioid analgesics among Ontario students. Canadian Family Physician 56, 256-262.
7. Byrt T (1996). How good is agreement? Epidemiology 7, 561.
8. Canino G, Bravo M, Ramirez R, Febo VE, Rubio-Stipec M, Fernandez RL, Hasin D (1999). The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. Journal of Studies on Alcohol 60, 790-799. (Pubitemid 29526544)
9. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF (2005a). Prevalence and comorbidity of DSM-IV antisocial syndromes and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 66, 677-685. (Pubitemid 40942412)
10. Compton WM, Thomas YF, Conway KP, Colliver JD (2005b). Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry 162, 1494-1502. (Pubitemid 41105563)
11. Emrich HM, Vogt P, Herz A (1982). Possible antidepressive effects of opioids: action of buprenorphine. Annals of the New York Academy of Sciences 398, 108-112. (Pubitemid 13026039)
12. Fleiss JL (1981). Statistical Methods for Rates and Proportions, 2nd edn. John Wiley and Sons: New York.
13. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R (2003). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 71, 7-16. (Pubitemid 36734856)
14. Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP (1995). The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug and Alcohol Dependence 39, 37-44.
15. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Huang B (2005). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research 39, 1-9%. (Pubitemid 39422280)
16. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP (2004a). Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 65, 948-958.
17. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004b). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61, 807-816. (Pubitemid 39031120)
18. Grella CE, Karno MP, Warda US, Niv N, Moore AA (2009). Gender and co-morbidity among individuals with opioid use disorders in the NESARC study. Addictive Behaviors 34, 498-504.
19. Hasin D, Carpenter KM, McCloud S, Smith M, Grant BF (1997). The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug and Alcohol Dependence 44, 133-141. (Pubitemid 27129506)
20. Hasin DS, Goodwin RD, Stinson FS, Grant BF (2005). Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry 62, 1097-1106. (Pubitemid 41396935)
21. Hatzenbuehler ML, Keyes KM, Narrow WE, Grant BF, Hasin DS (2008). Racial/ethnic disparities in service utilization for individuals with co-occurring mental health and substance use disorders in the general population: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 69, 1112-1121. (Pubitemid 352031595)
22. Haydon E, Rehm J, Fischer B, Monga N, Adlaf E (2005). Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Canadian Journal of Public Health 96, 459-461. (Pubitemid 41762923)
23. Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, Smith SM, Goldstein RB, Grant BF (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67, 1062-1073. (Pubitemid 44230877)
24. Kendler KS, Prescott CA, Myers J, Neale MC (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry 60, 929-937. (Pubitemid 37122313)
25. Krueger RF, McGue M, Iacono WG (2001). The higher-order structure of common DSM mental disorders: internalization, externalization, and their connections to personality. Personality and Individual Differences 30, 1234-1259.
26. Kuehn BM (2007). Prescription drug abuse rises globally. JAMA 297, 1306. (Pubitemid 46513252)
27. Lyons M, Hitsman B, Xian H, Panizzon MS, Jerskey BA, Santangelo S, Grant MD, Rende R, Eisen S, Eaves L, Tsuang MT (2008). A twin study of smoking, nicotine dependence, and major depression in men. Nicotine and Tobacco Research 10, 97-108.
28. Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD (2009a). Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 103, 16-24.
29. Martins SS, Storr CL, Zhu H, Chilcoat HD (2009b). Correlates of extramedical use of Oxycontin1 and other analgesic opioids among the US general population. Drug and Alcohol Dependence 99, 58-67.
30. McCabe SE, Cranford JA, Boyd CJ, Teter CJ (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors 32, 562-575. (Pubitemid 46038570)
31. Monheit B (2010). Prescription drug misuse. Australian Family Physician 39, 541-546.
32. Robinson J, Sareen J, Cox BJ, Bolton JM (2011). Role of self-medication in the development of comorbid anxiety and substance use disorders. Archives of General Psychiatry 68, 800-806.
33. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004). Potential anxiolytic and antidepressant-like activities of SNC80, a selective d-opioid agonist, in behavioral models in rodents. Journal of Pharmacological Sciences 95, 374-380. (Pubitemid 39037898)
34. Schepis TS, Hakes JK (2011). Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction. Published online: 1 June 2011. doi:10.1111/j.1360-0443.2011.03520.x.
35. Substance Abuse and Mental Health Services Administration Office of Applied Studies (2005). Results from the 2004 National Survey on Drug Use and Health: National Findings. DHHS publication no. SMA 05-4062, NSDUH series H-28.
36. SAMHSA: Rockville, MD. Substance Abuse and Mental Health Services Administration Office of Applied Studies (2006). Results from the 2005 National Survey on Drug Use and Health: National Health Findings. DHHS publication no. SMA 07-4293, NSDUH series H-32.
37. SAMHSA: Rockville, MD. Substance Abuse and Mental Health Services Administration (2009). Results from the 2008 National Survey on Drug Use and Health: National Findings. HHS publication no. SMA 09-4434, NSDUH series H-36.
38. SAMHSA: Rockville, MD. Substance Abuse and Mental Health Services Administration (2010). TEDS Report: Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008. SAMHSA: Rockville, MD.
39. Sullivan ED, Edlund MJ, Steffick D, Unü tzer J (2005). Regular use of prescribed opioids: association with common psychiatric disorders. Pain 119, 95-103. (Pubitemid 41752969)
40. Szklo M, Javier-Nieto F (2004). Quality assurance control. In Epidemiology: Beyond the Basics (ed. M. Sklo and F. Javier Nieto), p. 377. Jones and Bartlett Publishers: Sudbury, MA.
41. Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE (2008). Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 103, 258-268.
42. Walwyn WM, Miotto KA, Evans CJ (2010). Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug and Alcohol Dependence 108, 156-165.
43. Weber MM, Emrich HM (1988). Current and historical concepts of opiate treatment in psychiatric disorders. International Clinical Psychopharmacology 3, 255-266.
44. Young SE, Smolen A, Corley RP, Krauter KS, DeFries JC, Crowley TJ, Hewitt JK (2002). Dopamine transporter polymorphism associated with externalizing behavior problems in children. American Journal of Medical Genetics 114, 144-149. (Pubitemid 34160464)